From 1990 to 2019, the global age-standardized incidence rate of chronic kidney disease due to type 2 diabetes in adults aged 20-59 years increased by 21.8% to 30.3 per 100,000.
Observational
The global burden of CKD-T2D in adults aged 20-59 years has significantly increased from 1990 to 2019, driven largely by population growth, aging, high body-mass index, and high systolic blood pressure.
Population structure and lifestyles may have contributed to the epidemiological status of Chronic Kidney Disease due to Type 2 Diabetes (CKD-T2D). This study is a secondary data analysis. Using data from the Global Burden of Disease Study, we describe the changes in CKD-T2D burden and its influencing factors in the population aged 20-59 years from 1990 to 2019. Globally, the incidence, death, and Disability Adjusted Life Years (DALYs) rate of CKD-T2D showed an upward trend and increased with age, and the burden in males was higher than that in females. Population growth and aging were important driving factors for the increase of CKD-T2D DALY burden, while high systolic blood pressure and high body-mass index were the primary attributable risk factors. High body-mass index exhibited higher contributions to high Socioeconomic Development Index (SDI) countries, whereas low SDI countries were more impacted by high systolic blood pressure. The population attributable fraction of CKD-T2D DALY caused by high body-mass index was positively correlated with SDI, while high temperature and lead exposure were negatively correlated. Therefore, strengthening disease screening for people aged 20-59 years and formulating early intervention measures based on the level of socioeconomic development may effectively alleviate the burden of CKD-T2D.
Xie et al. (Sun,) conducted a observational in Chronic kidney disease due to type 2 diabetes (CKD-T2D). From 1990 to 2019, the global age-standardized incidence rate of chronic kidney disease due to type 2 diabetes in adults aged 20-59 years increased by 21.8% to 30.3 per 100,000.